Rebecca N. Kumar

ORCID: 0000-0001-6650-0612
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Mechanical Circulatory Support Devices
  • SARS-CoV-2 and COVID-19 Research
  • Renal Transplantation Outcomes and Treatments
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS drug development and treatment
  • Herpesvirus Infections and Treatments
  • HIV-related health complications and treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Cardiac Structural Anomalies and Repair
  • Bacillus and Francisella bacterial research
  • Antifungal resistance and susceptibility
  • Long-Term Effects of COVID-19
  • Simulation-Based Education in Healthcare
  • Poxvirus research and outbreaks
  • HIV/AIDS Research and Interventions
  • Cardiac Arrest and Resuscitation
  • Social Media in Health Education
  • Mycobacterium research and diagnosis
  • Nosocomial Infections in ICU
  • Organ Transplantation Techniques and Outcomes
  • Hepatitis C virus research
  • Mobile Health and mHealth Applications

MedStar Georgetown University Hospital
2016-2025

Georgetown University
2016-2025

International Society for Heart and Lung Transplantation
2023-2024

IFC Research (United Kingdom)
2024

Georgetown University Medical Center
2021-2023

Advanced Circulatory System (United States)
2023

John Wiley & Sons (United States)
2023

Hudson Institute
2023

Liechtenstein Institute
2023

Northwestern University
2019-2021

Monkeypox virus (MPXV) is an orthopoxvirus in the Poxviridae family. The current multinational monkeypox outbreak has now spread to 96 countries that have not historically reported monkeypox, with most cases occurring among gay, bisexual, and other men who sex (1,2). first case United States associated this was identified May 2022 Massachusetts (1); been all 50 states, District of Columbia (DC), one U.S. territory. MPXV transmitted by close contact infected persons or animals; infection...

10.15585/mmwr.mm7138e1 article EN MMWR Morbidity and Mortality Weekly Report 2022-09-13

Coronavirus disease 2019 (COVID-19) has strained healthcare systems with patient hospitalizations and deaths. Anti-spike monoclonal antibodies, including bamlanivimab, have demonstrated reduction in hospitalization rates clinical trials, yet real-world evidence is lacking.We conducted a retrospective case-control study across single system of nonhospitalized patients, age 18 years or older, documented positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, risk factors...

10.1093/cid/ciab305 article EN other-oa Clinical Infectious Diseases 2021-04-07

Abstract The number of transplant infectious disease (TID) fellowship programs has expanded rapidly in the past 5 years, with creation many new and expansion training tracks dedicated years as demand for TID physicians grows drastically. This editorial focuses on major factors complexities that should consider creation, well highlighting examples formative experiences, programmatic structure, fellow resources trainees can use to identify their desired career path TID. image

10.1111/tid.14247 article EN Transplant Infectious Disease 2024-02-13

Peter W. Schreiber, MD; Linard D. Hoessly, PhD; Katia Boggian, Dionysios Neofytos, MD, MPH; Christian van Delden, Adrian Egli, Michael Dickenmann, Cédric Hirzel, Oriol Manuel, MER; Koller, Simona Rossi, Vanessa Banz, Philippe Compagnon, Philipp Dutkowski, Andreas E. Kremer, PhD, MHBA; Annalisa Berzigotti, Julien Vionnet, Nicolas Goossens, David Semela, Patrizia Künzler-Heule, Christine Bernsmeier, Stefan P. Kuster, MSc, eMBA; Susanne Stampf, J. Mueller, Swiss Transplant Cohort Study; Amico;...

10.1001/jamanetworkopen.2025.1342 article EN cc-by-nc-nd JAMA Network Open 2025-03-21

<sec> <title>BACKGROUND</title> The COVID-19 pandemic prompted an abrupt transition to telemedicine for HIV care, necessitating exploration of provider attitudes and experiences understand future viability impact. </sec> <title>OBJECTIVE</title> We conducted a convergent mixed methods study evaluate explore the towards among providers at clinics in Chicago area. <title>METHODS</title> This mixed-methods assessed with surveys two time points key informant interviews. Surveys were administered...

10.2196/preprints.75933 preprint EN 2025-04-13

ABSTRACT As part of an ongoing series social media discussions, the Transplant Infectious Diseases Early Career Network hosted open forum for transplant infectious disease community to discuss development research careers junior faculty. Topics discussed included opportunities research, identifying potential questions, institutional support, grant funding, common barriers and trainee involvement. The highlighted symbiotic relationships between faculty trainees. insights from provide a...

10.1111/tid.70041 article EN cc-by-nc-nd Transplant Infectious Disease 2025-04-29

Evaluating organ suitability for transplantation based on infection risk is a core competency in transplant infectious disease (TID). It unclear if trainees have opportunities to practice during training. We created simulation curriculum develop and evaluate this skill among (ID) trainees.We six questions about risk. During trainees' TID rotations, faculty texted or paged the cases posing as coordinator. Trainees had 15 min ask before deciding of explained their clinical reasoning survey....

10.1111/tid.14177 article EN Transplant Infectious Disease 2023-11-01

Donor-derived infections in solid organ transplantation can be prevented by risk stratification of donors based on available information, and inquiries surrounding possible or diagnosed infection are common questions posed to transplant infectious disease subspecialists. This article outlines the five key steps addressing a donor call from team systematic approach, focusing recipient-specific factors, transmissibility treatment infections, likelihood patient's future offers mortality...

10.1111/tid.14172 article EN Transplant Infectious Disease 2023-11-08

Bartonella quintana infection can cause severe disease that includes clinical manifestations such as endocarditis, chronic bacteremia, and vasoproliferative lesions of the skin viscera. B. bacteria is transmitted by human body louse (Pediculus humanus corporis) associated with homelessness limited access to hygienic services. We report in 2 kidney transplant recipients United States from an organ donor who was experiencing homelessness. One manifested atypically, other minimally symptomatic;...

10.3201/eid3012.240310 article EN cc-by Emerging infectious diseases 2024-11-29

Creating protocols surrounding the guidance of prevention and treatment infections in transplantation is an integral part being a transplant infectious disease physician. This piece outlines key components for success developing protocol, with example protocol template available readers. Collaborating effectively within multi-disciplinary team to develop, implement, assess efficacy skill that enhances relationship our colleagues improves patient outcomes by standardizing care delivered.

10.1111/tid.14149 article EN Transplant Infectious Disease 2023-09-25

ABSTRACT Hypermutator lineages of Pseudomonas aeruginosa arise frequently during the years airway infection experienced by patients with cystic fibrosis and bronchiectasis but are rare in absence chronic structural lung disease. Since onset COVID-19 pandemic, large numbers have remained mechanically ventilated for extended periods time. These prone to acquire bacterial pathogens that persist many weeks opportunity evolve within pulmonary environment. However, little is known about what types...

10.1128/msystems.00484-23 article EN cc-by mSystems 2023-12-22
Jason D. Christie Christian Benden Andreas Zuckerman Martin Goddard P. Hopkins and 95 more Caron Burch Marc de Perrot Daniel F. Dilling Mardi Gomberg‐Maitland Angela Lorts J. Patel Yael Peled Laurie D. Snyder Josef Stehlik Simon Urschel Greg Schultz Aaron Cae Jacky Adair Sue Bessner J. I. Burke Megan Barrett Susie Newton Alyssa Simpson Joanne Singletary Olivia Penninger Göran Dellgren Howard J. Eisen Kiran K. Khush Javier Carbone Chesney Castleberry Sharon Chih Canada Depasquale Jonathan Hand E. Henricksen Harveen K. Lamba Clive Lewis M Mbbchir King- Dom Miller Arne Neyrinck David A. Baran Estela Azeka Jennifer Conway Fabienne Dobbels Cesar Guerrero-Miranda Ivan Kneževič Jill C. Krisl Rebecca N. Kumar Anna Sina P. Meyer Nina Pilat Carmela D. Tan Alessandra Sef United Kingdom Wiebke Sommer Brandi A. Bottiger Silvia Campos Carol Farver John R. Greenland Don Hayes S. Ivulich Brittany Koons Jesper Magnusson M.A. Malouf Tereza Martinu Canada Perch Dirk Van Raemdonck Palak Shah Yaron D. Barac Jen Cook Hannah Copeland José González‐Costello Spain Horn Oliver Miera Ezequiel Molina Sarah Schettle Thomas Schlöglhofer Jaimin Austria Barbara Trivedi Raymond L. Benza Bailey Colvin Clara Hjalmarsson Rebecca Klingbeil Christoph Knosalla Nicholas A. Kolaitis Deborah A. Levine Micheal McInnis Erika Rosenzweig Stefan Söderberg Rayid Abdulqawi Saudi Arabia Rosalyn Adigun Maxwell Afari Aasim Afzal Richa Agarwal Akanksha Agrawal Miriam Aguilar Perez Mustafa Ahmed Clemens Aigner Nathan Airhart Sophia Airhart Waqas Akhtar

10.1016/s1053-2498(24)01540-7 article EN The Journal of Heart and Lung Transplantation 2024-04-01

10.1007/s40506-024-00278-x article EN Current treatment options in infectious diseases/Current treatment options in infectious disease 2024-10-23

Infection is a leading cause of morbidity and mortality in patients with ventricular assist devices (VAD). The impact colonization multidrug-resistant organisms (MDRO) on outcomes this cohort unknown. Patients VAD support from July 2008 to September 2018 at single site were evaluated for MDRO after implantation. MDROs included methicillin-resistant Staphylococcus aureus , vancomycin-resistant Enterococcus species, extended-spectrum beta-lactamase producing gram-negative bacteria. 378 433...

10.1097/mat.0000000000001634 article EN ASAIO Journal 2021-12-28
Coming Soon ...